ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Wazza222
|
82K |
49M |
6 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
82K
|
49M
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Wazza222
|
350 |
269K |
0 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
350
|
269K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Wazza222
|
350 |
269K |
0 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
350
|
269K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
AVZO options
|
|
Wazza222
|
730 |
288K |
4 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
730
|
288K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Wazza222
|
111 |
71K |
0 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
111
|
71K
|
0
|
|
ASX - By Stock
|
KOR |
Re:
Ann: Quarterly Activities Report
|
|
Wazza222
|
73 |
258K |
1 |
08/02/20 |
08/02/20 |
ASX - By Stock
|
73
|
258K
|
1
|
|
ASX - By Stock
|
KOR |
Re:
Ann: Quarterly Activities Report
|
|
Wazza222
|
73 |
258K |
2 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
73
|
258K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Wazza222
|
111 |
71K |
22 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
111
|
71K
|
22
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Wazza222
|
111 |
71K |
2 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
111
|
71K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Wazza222
|
111 |
71K |
15 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
111
|
71K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
Proposal to be considered at EGM
|
|
Wazza222
|
122 |
66K |
16 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
122
|
66K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Proposal to be considered at EGM
|
|
Wazza222
|
122 |
66K |
10 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
122
|
66K
|
10
|
|
ASX - By Stock
|
KOR |
Re:
Ann: Extension of rights issue closing date
|
|
Wazza222
|
128 |
39K |
4 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
128
|
39K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Proposal to be considered at EGM
|
|
Wazza222
|
122 |
66K |
11 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
122
|
66K
|
11
|
|
ASX - By Stock
|
KOR |
Re:
Ann: Extension of rights issue closing date
|
|
Wazza222
|
128 |
39K |
2 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
128
|
39K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AHZO
|
|
Wazza222
|
14 |
7.5K |
1 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
14
|
7.5K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AHZO
|
|
Wazza222
|
14 |
7.5K |
0 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
14
|
7.5K
|
0
|
|
ASX - By Stock
|
AVR |
AHZO
|
|
Wazza222
|
14 |
7.5K |
3 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
14
|
7.5K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
Wazza222
|
20K |
16M |
2 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
20K
|
16M
|
2
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
Wazza222
|
20K |
16M |
1 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
20K
|
16M
|
1
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Becoming a substantial holder
|
|
Wazza222
|
50 |
21K |
2 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
50
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Proactive interview with Wayne Paterson
|
|
Wazza222
|
35 |
18K |
0 |
22/11/19 |
22/11/19 |
ASX - By Stock
|
35
|
18K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Proactive interview with Wayne Paterson
|
|
Wazza222
|
35 |
18K |
1 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
35
|
18K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Grants Option to Consumer Health Division of Sanofi
|
|
Wazza222
|
264 |
162K |
20 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
264
|
162K
|
20
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Paediatric Study Published In Peer-Reviewed Journal
|
|
Wazza222
|
275 |
133K |
0 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
275
|
133K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Revenue
|
|
Wazza222
|
113 |
38K |
1 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
113
|
38K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Wazza222
|
275 |
160K |
10 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
275
|
160K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Wazza222
|
51 |
24K |
6 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
51
|
24K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Wazza222
|
51 |
24K |
1 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
51
|
24K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
Wazza222
|
58 |
27K |
0 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
58
|
27K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
Wazza222
|
58 |
27K |
1 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
58
|
27K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
Wazza222
|
58 |
27K |
0 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
58
|
27K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
Wazza222
|
162 |
84K |
3 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
162
|
84K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
Wazza222
|
162 |
84K |
12 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
162
|
84K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
Wazza222
|
162 |
84K |
8 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
162
|
84K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Wazza222
|
7 |
5.7K |
6 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
7
|
5.7K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Wazza222
|
242 |
110K |
11 |
23/08/19 |
23/08/19 |
ASX - By Stock
|
242
|
110K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Circulation Research Highlights MSB Heart Failure Therapy
|
|
Wazza222
|
36 |
16K |
10 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
36
|
16K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Wazza222
|
314 |
125K |
6 |
30/06/19 |
30/06/19 |
ASX - By Stock
|
314
|
125K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: BTC: BTC health to acquire Hospital Infusion Business
|
|
Wazza222
|
3 |
2.2K |
2 |
15/05/19 |
15/05/19 |
ASX - By Stock
|
3
|
2.2K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Facility Agreement with SIO Partners LP
|
|
Wazza222
|
94 |
31K |
7 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
94
|
31K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
Wazza222
|
170 |
65K |
1 |
03/05/19 |
03/05/19 |
ASX - By Stock
|
170
|
65K
|
1
|
|
ASX - By Stock
|
KOR |
Re:
News: KOR Korab Resources Says To Raise Funds Via Placement Of About 2.3 Mln Shares At 3.5 Cents...
|
|
Wazza222
|
81 |
15K |
0 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
81
|
15K
|
0
|
|
ASX - By Stock
|
KOR |
Re:
News: KOR Korab Resources Says To Raise Funds Via Placement Of About 2.3 Mln Shares At 3.5 Cents...
|
|
Wazza222
|
81 |
15K |
0 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
81
|
15K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Wazza222
|
5 |
3.7K |
19 |
23/04/19 |
23/04/19 |
ASX - By Stock
|
5
|
3.7K
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
Wazza222
|
170 |
65K |
2 |
23/04/19 |
23/04/19 |
ASX - By Stock
|
170
|
65K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
Wazza222
|
170 |
65K |
1 |
17/04/19 |
17/04/19 |
ASX - By Stock
|
170
|
65K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
52 |
18K |
0 |
12/04/19 |
12/04/19 |
ASX - By Stock
|
52
|
18K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Share Sale Agreement to sell Admedus Vaccines
|
|
Wazza222
|
21 |
11K |
2 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
21
|
11K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Pause In Trading
|
|
Wazza222
|
31 |
13K |
0 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
31
|
13K
|
0
|
|